News

(Bloomberg) -- CVS Health Corp. shares fell after the company gave preliminary 2027 profit guidance that disappointed investors and warned of challenges in its pharmacy benefit manager next year, overshadowing a better-than-expected second quarter report.Most Read from BloombergTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealSpaceX’s AI Splurge Puts Damper on Debut Earnings After IPOChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasi

CVS Health earnings surged past tepid forecasts after reporting its health benefit costs fell as a share of premiums. The pharmacy chain hiked its full-year outlook by a bit less than the Q2 beat. Analysts say that management's prudence in trying to grow its health benefits business let the company avoid the worst fallout from surprisingly strong medical care utilization.

Guardant Health (NASDAQ:GH) reported second-quarter 2026 revenue of $335 million, up 44% from a year earlier, as growth accelerated across its oncology, biopharma and data, and screening businesses. The company also raised its full-year revenue outlook, citing demand for its Guardant360 and Shield o

Humana (NYSE:HUM) said its 2026 performance is tracking in line with expectations, with management emphasizing planned Medicare Advantage margin expansion in 2027, progress in its Stars program and continued operating-cost reductions as key components of its path toward a sustainable pretax margin o

ENI (NYSE:E) reported sharply higher second-quarter and first-half results, citing upstream production growth, favorable market conditions and stronger contributions from its gas, low-carbon and refining-related businesses. Chief Executive Officer Claudio Descalzi said second-quarter pro forma EBIT

Humana’s shares dipped in morning trading after its results compared unfavorably with other insurers’ performance this quarter The Medicare-focused insurer modestly beat analysts’ profit projections, offered reassurance on medical cost trends and left guidance unchanged on an adjusted basis.

Humana reports earnings Wednesday after its stock surged this year on improving confidence in Medicare Advantage insurers. Investors will be watching medical costs and the company’s outlook.

CNC's Q2 earnings and revenues top estimates as stronger premium and service revenues drive results despite lower membership and higher medical costs.

HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.

UnitedHealth Group (UNH) just delivered the quarter battered shareholders have been waiting for. The health care company blew past Wall Street's profit prediction, increased its most widely monitored cost index, and boosted its full-year earnings outlook. The results seemed to vindicate investors ...

Molina healthcare has seen its stock edge down in recent days amid concerns about Medicaid cost pressures.

UnitedHealth Group (UNH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

UnitedHealth Group (UNH) beat Wall Street's numbers on July 16, 2026, but its chief financial officer spent the earnings call making sure nobody mistook that result for a solved cost problem. The company beat earnings estimates by roughly 30%, and management raised full-year guidance well past ...

The company doubled its 2026 buyback target to at least $5 billion after already repurchasing $4 billion of shares.

CEO Hemsley reports 55% operating earnings growth and raises full-year guidance.

UnitedHealth Group Incorporated will release earnings for its second quarter before the opening bell on Thursday, July 16. Analysts expect the company to report quarterly earnings of $4.85 per share, up from $4.08 per share in the year-ago period. The...

UnitedHealth shares jumped to their highest level in more than a year Thursday after the health care and insurance giant reported better-than-expected quarterly results.

UnitedHealth Group Inc (UNH) reports a significant rise in adjusted EPS and operating earnings, while navigating cost pressures and strategic investments in AI.

US benchmark equity indexes were lower intraday amid a sell-off in certain chip-related stocks as in

Q2 earnings are off to a strong start. Tech, Energy, Materials, Finance and Aerospace ETFs could shine as profit growth broadens across sectors.

The S&P 500 and Nasdaq Composite were down in late-morning trading Thursday, while the Dow Jones Ind

UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares climbed about 5% in post-market trading after the healthcare company reported second quarter results that beat Wall Street expectations and raised its full-year adjusted earnings outlook. For the quarter ended June 30, UnitedHealth reported...

The stock is still 25% off all-time highs.

UnitedHealth Group (NYSE:UNH) reported sharply higher second-quarter 2026 earnings and raised its full-year outlook, citing improved performance in Medicare Advantage and Optum Health, while cautioning that commercial medical cost trends remain elevated and are delaying margin recovery in that busin

While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.

UnitedHealth (UNH) raised its full-year earnings outlook on Thursday as the health insurance giant r

UnitedHealth Stock Rallies as Profit, Revenue Top Wall Street Expectations

US equity markets were mostly tracking in the red before the opening bell Thursday as traders await

The health insurance giant posted adjusted earnings of $6.38 per share, well above Wall Street estimates, and lifted its full-year adjusted profit guidance to $19.50–$20.00 per share